Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

CarMoney has expanded its board of directors

12/12/23 CARM

Samolet has summarized the preliminary results of 2023

12/12/23 SMLT

Mosgorlombard extended the period for collecting applications for participation in the IPO

12/12/23 MGKL

Samolet developer buys bank

12/12/23 SMLT

Henderson expects to earn more than ₽2 billion in profits in 2023

12/12/23 HNFG

Henderson's 2023 dividend will be at least ₽25 per share

12/12/23 HNFG

Samolet Plus service will hold a Pre-IPO in the first half of 2024

12/12/23 SMLT

RuStore appeared on readers and media players

12/12/23 VKCO

Retail space of Magnit network exceeded the mark of 10 mln sq. m.

12/12/23 MGNT

Rostelecom started construction of the third stage of the Trans-Eurasian FOCL network

12/12/23 RTKM